DERMATA THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
DERMATA THERAPEUTICS, INC. (DRMA) reported Stock Issued During Period, Shares, New Issues of 363.00 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-11-13
- 2024-09-30: Stock Issued During Period, Shares, New Issues 9 month 363.00K shares.
- 2021-06-30: Stock Issued During Period, Shares, New Issues 6 month 1.65M shares.
| Period end | Stock Issued During Period, Shares, New Issues 6 month | Stock Issued During Period, Shares, New Issues 9 month |
|---|---|---|
| 2024-09-30 | 363.00K shares 10-Q · filed 2024-11-13 | |
| 2021-06-30 | 1.65M shares 10-Q · filed 2021-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |